Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer

被引:23
|
作者
Obeng-Gyasi, Samilia [1 ]
Li, Yaming [2 ]
Carson, William E. [1 ]
Reisenger, Sarah [3 ]
Presley, Carolyn J. [3 ]
Shields, Peter G. [3 ]
Carbone, David P. [3 ]
Ceppa, DuyKhanh P. [4 ]
Carlos, Ruth C. [5 ]
Andersen, Barbara L. [6 ]
机构
[1] Ohio State Univ, Dept Surg, Div Surg Oncol, 410 W 10th Ave,Room N924 Doan Hall, Columbus, OH 43210 USA
[2] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA
[3] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[4] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
NATIONAL SAMPLE; WOMENS HEALTH; SURVIVAL; SCORE; ADAPTATION; DISEASE; STRESS;
D O I
10.1001/jamanetworkopen.2022.21626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Adverse social determinants of health (SDHs) (eg, poverty) are associated with poor oncologic outcomes among patients with lung cancer. However, no studies have evaluated biological correlates of adverse SDHs, operationalized as allostatic load (AL), with mortality due to lung cancer. OBJECTIVE To examine the association among AL, SDHs, and mortality among patients with metastatic non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study of an observational cohort was performed at a National Cancer Institute-designated comprehensive cancer center with data accrued from June 1, 2017, to August 31, 2019. Patients with metastatic (stage IV) NSCLC enrolled at diagnosis into a prospective observational cohort study were included in the present analysis if they had all the biomarkers to calculate an AL score (N = 143). Follow-up was completed on August 31, 2021, and data were analyzed from July 1 to September 30, 2021. EXPOSURES Social determinants of health. MAIN OUTCOMES AND MEASURES Overall mortality and AL. RESULTS A total of 143 patients met the study criteria with a median age of 63 (IQR, 55-71) years (89 men [62.2%] and 54 women [37.8%]). In terms of race and ethnicity, 1 patient (0.7%) was Asian, 7 (4.9%) were Black, 117 (81.8%) were White, 17 (11.9%) were of multiple races, and 1 (0.7%) was of other race or ethnicity. The mean (SD) AL was 2.90 (1.37). Elevated AL covaried with lower educational level (r = -0.26; P = .002), male sex (r = 0.19; P = .02), limited mobility (r = 0.19; P = .04), worsening self-care (r = 0.30; P < .001), problems engaging in usual activities (r = 0.21; P = .01), depressive symptoms (r = 0.23; P = .005), and a high number of stressful life events (r = 0.30; P < .001). Multivariable analysis found only increasing difficulty with mobility (r = 0.37 [95% CI, 0.13-0.60]; P = .002) and male sex (r = 0.63 [95% CI, 0.19-1.08]; P = .005) associated with higher AL. On adjusted analysis, elevated AL (hazard ratio, 1.43 [95% CI, 1.16-1.79]; P = .001) and low educational level (hazard ratio, 2.11 [95% CI, 1.03-4.34]; P = .04) were associated with worse overall mortality. CONCLUSIONS AND RELEVANCE The findings of this cross-sectional study suggest that higher AL was associated with adverse SDHs and worse overall mortality among patients with advanced NSCLC. These results provide a framework for replication and further studies of AL as a biological correlate for SDH and future prognostic marker.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Temporal Improvements in Overall Survival in Metastatic Non-Small Cell Lung Cancer in the United States Since 2004
    Danese, M.
    Lee, A.
    Su, I. -H.
    Yuan, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S422 - S423
  • [22] Association Between Body Mass Index and Survival in Patients with De Novo Metastatic Non-Small Cell Lung Cancer
    Urun, Muslih
    Guner, Gurkan
    Sezgin, Yasin
    Sakin, Abdullah
    Kilickap, Saadettin
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [23] Association of smoking with tumor size at diagnosis in non-small cell lung cancer
    Chen, Xing
    Gorlov, Ivan P.
    Merriman, Kelly W.
    Weng, Shih-Feng
    Foy, Millennia
    Keener, Gwendolyn
    Amos, Christopher I.
    Spitz, Margaret R.
    Kimmel, Marek
    Gorlova, Olga Y.
    LUNG CANCER, 2011, 74 (03) : 378 - 383
  • [24] Changing paradigm in advanced and metastatic non-small cell lung cancer
    Uprety, Dipesh
    Parikh, Kaushal
    Sawkar, Anita
    Dimou, Anastasios
    Leventakos, Konstantinos
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6992 - 7001
  • [25] Surgical Impacts of Metastatic Non-small Cell Lung Cancer to the Thoracic and Lumbar Spine
    Jung, Jong-Myung
    Hyun, Seung-Jae
    Kim, Ki-Jeong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (07) : 1 - 12
  • [26] Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer
    Kim, Kyung Hwan
    Pyo, Hongryull
    Lee, Hoyoung
    Oh, Dongryul
    Noh, Jae Myoung
    Ahn, Yong Chan
    Kim, Chang Gon
    Yoon, Hong In
    Lee, Jiyun
    Park, Sehhoon
    Jung, Hyun-Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ku, Bo Mi
    Shin, Eui-Cheol
    Ahn, Myung-Ju
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (02): : 464 - 475
  • [27] Muscle mass and association to quality of life in non-small cell lung cancer patients
    Bye, Asta
    Sjoblom, Bjorg
    Wentzel-Larsen, Tore
    Gronberg, Bjorn H.
    Baracos, Vickie E.
    Hjermstad, Marianne J.
    Aass, Nina
    Bremnes, Roy M.
    Flotten, Oystein
    Jordhoy, Marit
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (05) : 759 - 767
  • [28] Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?
    Aydiner, Adnan
    Ciftci, Rumeysa
    Karabulut, Senem
    Kilic, Leyla
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 6109 - 6114
  • [29] Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer
    Goto, Taichiro
    Kunimasa, Kei
    Hirotsu, Yosuke
    Nakagomi, Takahiro
    Yokoyama, Yujiro
    Higuchi, Rumi
    Otake, Sotaro
    Oyama, Toshio
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    CANCERS, 2020, 12 (11) : 1 - 16
  • [30] Overall Survival and Intermediate Outcomes among Scandinavian Non-Small Cell Lung Cancer Patients: The SCAN-LEAF Study
    Ekman, Simon
    Sorensen, Jens Benn
    Rockberg, Julia
    Sandelin, Martin
    Daumont, Melinda
    Sobocki, Patrik
    Klint, Peter
    Huang, Han-Yao
    Svard, Jenny
    Chirita, Oana
    Jorgensen, Leif
    Planck, Maria
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S6391 - S6391